Edgewise Therapeutics taps new CFO

BOULDER — Edgewise Therapeutics Inc. has hired R. Michael Carruthers, a longtime finance head for Boulder-area pharmaceutical firms, as its first-ever chief financial officer.

Carruthers has more than two decades in the Boulder pharmaceutical industry under his belt, including with two companies that have been acquired in the past five years.

He was CFO at Array Biopharma Inc. from 1998 to 2015, which was acquired by pharma giant Pfizer Inc. (NYSE: PFE) four years later for $11.4 billion.

He then joined Nivalis Therapeutics, a cystic fibrosis-focused company that merged with Seattle-based Alpine…